Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept Combined With Nasal Insulin in Recently-diagnosed Type 1 Diabetes
NCT05742243Phase 2Completed
- Sponsor
- Melbourne Health
- Start
- Feb 2023
- Primary completion
- Sep 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of intranasal insulin in type 1 diabetes mellitus (T1D), sponsored by Melbourne Health. Started Feb 2023; status: completed.
02
Drugs
intranasal insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05742243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05742243.